Cyendiv 100mg capsule

• Idiopathic pulmonary fibrosis
• Non-small cell lung cancer

Most side effects of Cyendiv 100mg capsule do not require medical attention as they may disappear as your body adjusts to the medicine. In case these side effects become worse, consult your doctor immediately.
Common side effects include:

• Abdominal pain
• Diarrhea
• Nausea
• Vomiting
• Abnormal liver function tests
• Loss of appetite
• Headache
• Weight loss
• High blood pressure

• Doctor determines the exact dose and duration with Cyendiv 100mg capsule as per the overall health condition of the patient. The typical recommended dose of the capsule is twice daily.
• This capsule should be taken with food, but at the fix time every day to get effective results. Don't miss a dose or overdose on the medicine. Swallow it as a whole with a glass of water and do not crush, chew, or open it.
  

• Cyendiv 100mg capsule is an anticancer medicine that contains nintedanib. This medicine works by inhibiting the pathways responsible for fibrosis and reducing the scarring & swelling in the lungs results in better breath.
• It also blocks the action of abnormal protein to stop or slow the spread of cancer cells.
  

• Praphawatvet, T. (2023). Dry powder for inhalation of single and fixed dose combinations of nintedanib, pirfenidone and mycophenolic acid prepared by thin-film freezing technology (Doctoral dissertation).
• Velagacherla, V., Suresh, A., Mehta, C. H., & Nayak, U. Y. (2021). Advances and challenges in nintedanib drug delivery. Expert opinion on drug delivery, 18(11), 1687-1706.
• Yun, C. X., Huan, M. L., Zhu, X., Wan, Y. H., Zou, J. B., & Zhang, B. L. (2024). Construction of the pulmonary bio-adhesive delivery system of nintedanib nanocrystalline for effective treatment of pulmonary fibrosis. International Journal of Pharmaceutics, 660, 124302.
• Wang, J., Zhang, S., Tan, C., Wei, Q., & Xiong, S. (2023). Simultaneously inhibiting P-gp Efflux and drug recrystallization enhanced the oral bioavailability of nintedanib. Current Pharmaceutical Biotechnology, 24(15), 1972-1982.
• Thakkar, D., Singh, S., & Wairkar, S. (2024). Advanced delivery strategies of nintedanib for lung disorders and beyond: A comprehensive review. AAPS PharmSciTech, 25(6), 150.